Novo Integrated Sciences Inc (NVOS)

[scooby3]

Read the November 10Q Report

For the nine months ended September 30, 2014, the Company had a net loss of $705,245. As of September 30, 2014, the Company has a working capital deficit of $248,121. In view of these matters, the Company’s ability to continue as a going concern is dependent upon the Company’s ability to begin operations and to achieve a level of profitability. The Company intends on financing its future development activities and its working capital needs largely from the sale of public equity securities with some additional funding from other traditional financing sources, including term notes and proceeds from sub-licensing agreements until such time that funds provided by operations are sufficient to fund working capital requirements.